Genmab
Aktiesnakken
NOVO
Zealand Pharma
TESLA
Genmab
Bavarian Nordic
Forsvarsaktier
Biotek-snakken
Amerikanske aktier
ExpreS2ion
Gubra
Hansa Biopharma
Medico
Pharma
Shipping
Vestas
AMBU
GN Store Nord
BITCOIN
Ennogie
Grønne Aktier
Banker og Finans
OLIE OG GAS
Chemometec
Laks
Smallcap og First North aktier
![]() |
12/6 10:09 af GeorgeBest |
yes
|
![]() |
12/6 10:08 af E L |
lol - did anyone listen to the Fireside Chat with Anthony Pagano yesterday?
|
![]() |
12/6 10:05 af Mcjean |
nope its only brokers there fooling around these days
|
![]() |
12/6 10:02 af E L |
10. on epco only. that is a lot. i don't think I had heard that yet? They are not fooling around...
|
![]() |
12/6 10:00 af E L |
Jefferies also said "Together with Abbvie, Genmab is planning a major development program with about ten studies, most of which are phase 3"
|
![]() |
12/6 09:08 af Helge Larsen/PI-redaktør |
Kursen holder sig flot her til morgen i forhold til anden pharma/biotek.
|
![]() |
12/6 08:35 af Peree |
Jeg tror der skal købes op diverse steder idag :)
|
![]() |
12/6 08:34 af GeorgeBest |
GENMAB A/S GMAB.CO : JP MORGAN RAISES PRICE TARGET TO DKK 1950 FROM DKK 1850 - Reuters News
|
![]() |
12/6 08:33 af bibob |
Yes. A pretty Big raise. ;-)
|
![]() |
12/6 08:30 af E L |
and it gives a good insight in what they value amyloidosis, they raise with 245dkk
|
![]() |
12/6 08:28 af E L |
interesting to see Jefferies raise epco sales expectations based on Abbvies commercial strength
|
![]() |
12/6 08:14 af Helge Larsen/PI-redaktør |
Genmab: Epcoritamab video:
(link)
|
![]() |
12/6 08:04 af Helge Larsen/PI-redaktør |
Asien kun med beherskede fald i nat.
|
![]() |
12/6 07:47 af Helge Larsen/PI-redaktør |
|
![]() |
12/6 07:46 af Helge Larsen/PI-redaktør |
God morgen. :-)
|
![]() |
12/6 07:44 af GeorgeBest |
Tak LLI
|
![]() |
12/6 07:29 af bibob |
@LLI. Linket dur ikke.
|
![]() |
12/6 06:57 af bibob |
Aktiemarkedet er som kvinder. Man lærer aldrig at forstå dem. :-D
|
![]() |
12/6 06:56 af transalp |
Go morgen.. :) Hvornår mon jeg lære det at have 20% kontant, de kan tjene penge, i det her skøre marked.. c') :)
|
![]() |
12/6 06:51 af bibob |
GMAB US. -0,97 ( - 3,21 % )
|
![]() |
12/6 06:49 af bibob |
God morgen. :-).
|
![]() |
11/6 21:53 af kkjoel |
Oh, btw.. what excellent articles on Evaluate!
|
![]() |
11/6 21:51 af kkjoel |
Both the BioNTech presentation and the new GEN video on epco were interesting. Hats off, EL, for all your gathering and sharing information on everything-Genmab :-)
|
![]() |
11/6 21:11 af E L |
new video on the mechanism of action of epcoritamab (DuoBody®-CD3xCD20) (link)
|
| ||
![]() |
11/6 20:57 af Helge Larsen/PI-redaktør |
NBI -4,10%
|
![]() |
11/6 19:58 af Mcjean |
Nice article thx E L
|
![]() |
11/6 19:11 af E L |
New Genmab/Abbvie tie-up rings old bells (link)
|
![]() |
11/6 16:59 af E L |
BioNtech presentation from early June pdf (link)
|
![]() |
11/6 15:46 af Helge Larsen/PI-redaktør |
Join Genmab at the virtual edition of EHA Annual Congress. Visit our booth to get latest information about our presentations, antibody technology platforms and product pipeline.
(link)
|
![]() |
11/6 14:55 af GeorgeBest |
Nightmare scenario, but in some years you will probably follow the presentations from at least 10 companies who have in licensed products from Genmab :-)
|
![]() |
11/6 14:49 af E L |
lol GB , imagine they would have made 7 deals yesterday with 7 different companies for these 7 antibodies
;-)
|
![]() |
11/6 14:46 af OHW |
så så, nævn ikke det navn, no go her på siten..
|
![]() |
11/6 14:44 af kkjoel |
He he.. de har købt en manufacturing facility.. og de er ved at udvide den.. OG de vil bygge endnu en. De kan LIGE VOVE PÅ at lave en Lisa!
|
![]() |
11/6 14:41 af GeorgeBest |
keep us updated
|
![]() |
11/6 14:40 af GeorgeBest |
Its a full time job for you to keep up updated E L ;-)
|
![]() |
11/6 14:28 af E L |
and Seattle Genetics from minute 13:50 for TV
(link)
|
![]() |
11/6 14:10 af GeorgeBest |
thanks E L
|
![]() |
11/6 13:57 af E L |
Abbvie at GS conference from minute 29 (link)
|
![]() |
11/6 13:49 af kkjoel |
Jeg har noteret 30 finanshusmål med snit på 1931.
|
![]() |
11/6 13:48 af kkjoel |
Og nu osse H.C. Wainright ($40 ~ 2620 (kurs 6,55)) samt Suntrust Robinson ($39 ~ 2555).
|
![]() |
11/6 13:26 af GeorgeBest |
Jo UBS og Citi har 2500
|
![]() |
11/6 13:25 af bikube |
MedWatch påstår, at Guggenheims nye kursmål på 2350 er det hidtil højeste. Har vi ikke set mål på 2500?
|
![]() |
11/6 13:01 af GeorgeBest |
GENMAB A/S GMAB.O: SUNTRUST ROBINSON RAISES TARGET PRICE TO $39 FROM $36 - Reuters News
|
![]() |
11/6 12:37 af E L |
H.C. Wainwright analyst Raghuram Selvaraju raised the firm's price target on Genmab to $40 from $34 and keeps a Buy rating on the shares. The analyst views AbbVie as a "solid partner" for Genmab alongside Janssen
(link)
|
![]() |
11/6 12:26 af E L |
Genmab/Citi: Abbvie-aftale er bedre end ventet (link)
|
![]() |
11/6 11:54 af E L |
ok
|
![]() |
11/6 11:53 af Sukkeralf |
E L - pretty sure Jan said that. But it could be a small amount
|
![]() |
11/6 11:53 af Solsen |
Yes but the question yesterday was - is
these programs in clinical developement alredy. NO
|
![]() |
11/6 11:52 af E L |
are
you sure it is not included?
|
![]() |
11/6 11:51 af Sukkeralf |
E L - and there is a opt in payment thats not included in the 2 billion milestones
|